Maternal serum pregnancy-associated plasma protein-A and free β-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos fromin vitro fertilization and intracytoplasmic sperm injection
- 1 May 2005
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 25 (5) , 390-393
- https://doi.org/10.1002/pd.1169
Abstract
Objective Maternal serum pregnancy‐associated plasma protein‐A (PAPP‐A) and free β‐human chorionic gonadotrophin (β‐hCG) are useful markers in the screening of Down syndrome in the first trimester. We investigated the effect of intracytoplasmic sperm injection (ICSI), freezing and thawing of embryos on the levels of these two analytes in assisted reproduction pregnancies. Methods We recruited 149 women who conceived after assisted reproduction with fresh embryos (92 from conventional IVF and 57 from ICSI), 85 women who conceived with frozen‐thawed embryos (54 from conventional IVF and 31 from ICSI) and 401 women with spontaneous conceptions as controls. The concentrations of PAPP‐A and free β‐hCG were measured between 10 and 14 weeks and were converted to multiples of medians (MoM) for comparisons. Results Median PAPP‐A MoMs were significantly reduced in ICSI pregnancies in the fresh and frozen‐thawed embryo subgroups (0.70 and 0.66 MoM respectively) and in the IVF fresh embryo subgroups (0.83 MoM), as compared to controls (1.00 MoM). Free β‐hCG MoM was significantly reduced in the IVF fresh embryos subgroup (0.87 MoM), but not in the other three subgroups. Conclusion Further studies for exploring the underlying pathophysiology and adjustment in the marker levels for screening of Down syndrome are warranted in pregnancies conceived after assisted reproduction. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 44 references indexed in Scilit:
- Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screeningPrenatal Diagnosis, 2004
- Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years prospective experienceBJOG: An International Journal of Obstetrics and Gynaecology, 2003
- First-trimester screening for Down’s syndrome in in vitro fertilization pregnanciesFertility and Sterility, 2001
- First trimester markers of trisomy 21 and the influence of maternal cigarette smoking statusPrenatal Diagnosis, 2000
- The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free ?-hCG and PAPP-A at 10-14 weeks of gestationPrenatal Diagnosis, 2000
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 1999
- Screening of Maternal Serum for Fetal Down's Syndrome in the First TrimesterNew England Journal of Medicine, 1998
- Down syndrome screening in an asian population using alpha-fetoprotein and free β-hcg: a report of the taiwan down syndrome screening groupObstetrics & Gynecology, 1996
- Screening for Down's syndrome.BMJ, 1992
- The Effect of Smoking During Pregnancy on the Incidence of Low Birth Weight Among Chinese ParturientsAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1992